687 related articles for article (PubMed ID: 20185762)
21. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.
Risérus U; Sprecher D; Johnson T; Olson E; Hirschberg S; Liu A; Fang Z; Hegde P; Richards D; Sarov-Blat L; Strum JC; Basu S; Cheeseman J; Fielding BA; Humphreys SM; Danoff T; Moore NR; Murgatroyd P; O'Rahilly S; Sutton P; Willson T; Hassall D; Frayn KN; Karpe F
Diabetes; 2008 Feb; 57(2):332-9. PubMed ID: 18024853
[TBL] [Abstract][Full Text] [Related]
22. Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation.
Coll T; Jové M; Rodríguez-Calvo R; Eyre E; Palomer X; Sánchez RM; Merlos M; Laguna JC; Vázquez-Carrera M
Diabetes; 2006 Oct; 55(10):2779-87. PubMed ID: 17003343
[TBL] [Abstract][Full Text] [Related]
23. Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes.
Robciuc MR; Skrobuk P; Anisimov A; Olkkonen VM; Alitalo K; Eckel RH; Koistinen HA; Jauhiainen M; Ehnholm C
PLoS One; 2012; 7(10):e46212. PubMed ID: 23056264
[TBL] [Abstract][Full Text] [Related]
24. The PPARδ Agonist GW501516 Improves Lipolytic/Lipogenic Balance through CPT1 and PEPCK during the Development of Pre-Implantation Bovine Embryos.
Idrees M; Xu L; El Sheikh M; Sidrat T; Song SH; Joo MD; Lee KL; Kong IK
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810173
[TBL] [Abstract][Full Text] [Related]
25. Fatty acid-induced NF-kappaB activation and insulin resistance in skeletal muscle are chain length dependent.
Hommelberg PP; Plat J; Langen RC; Schols AM; Mensink RP
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E114-20. PubMed ID: 18957619
[TBL] [Abstract][Full Text] [Related]
26. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
[TBL] [Abstract][Full Text] [Related]
27. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
28. Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells.
Jové M; Planavila A; Laguna JC; Vázquez-Carrera M
Endocrinology; 2005 Jul; 146(7):3087-95. PubMed ID: 15802498
[TBL] [Abstract][Full Text] [Related]
29. Genistein stimulates fatty acid oxidation in a leptin receptor-independent manner through the JAK2-mediated phosphorylation and activation of AMPK in skeletal muscle.
Palacios-González B; Zarain-Herzberg A; Flores-Galicia I; Noriega LG; Alemán-Escondrillas G; Zariñan T; Ulloa-Aguirre A; Torres N; Tovar AR
Biochim Biophys Acta; 2014 Jan; 1841(1):132-40. PubMed ID: 24013029
[TBL] [Abstract][Full Text] [Related]
30. PPARδ activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference.
Feng YZ; Nikolić N; Bakke SS; Boekschoten MV; Kersten S; Kase ET; Rustan AC; Thoresen GH
Arch Physiol Biochem; 2014 Feb; 120(1):12-21. PubMed ID: 23991827
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.
Kannisto K; Chibalin A; Glinghammar B; Zierath JR; Hamsten A; Ehrenborg E
Int J Mol Med; 2006 Jan; 17(1):45-52. PubMed ID: 16328010
[TBL] [Abstract][Full Text] [Related]
32. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
Luquet S; Lopez-Soriano J; Holst D; Gaudel C; Jehl-Pietri C; Fredenrich A; Grimaldi PA
Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor-δ activates endothelial progenitor cells to induce angio-myogenesis through matrix metallo-proteinase-9-mediated insulin-like growth factor-1 paracrine networks.
Han JK; Kim HL; Jeon KH; Choi YE; Lee HS; Kwon YW; Jang JJ; Cho HJ; Kang HJ; Oh BH; Park YB; Kim HS
Eur Heart J; 2013 Jun; 34(23):1755-65. PubMed ID: 21920965
[TBL] [Abstract][Full Text] [Related]
34. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
35. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome.
Tanaka T; Yamamoto J; Iwasaki S; Asaba H; Hamura H; Ikeda Y; Watanabe M; Magoori K; Ioka RX; Tachibana K; Watanabe Y; Uchiyama Y; Sumi K; Iguchi H; Ito S; Doi T; Hamakubo T; Naito M; Auwerx J; Yanagisawa M; Kodama T; Sakai J
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15924-9. PubMed ID: 14676330
[TBL] [Abstract][Full Text] [Related]
36. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
37. Oleate dose-dependently regulates palmitate metabolism and insulin signaling in C2C12 myotubes.
Capel F; Cheraiti N; Acquaviva C; Hénique C; Bertrand-Michel J; Vianey-Saban C; Prip-Buus C; Morio B
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):2000-2010. PubMed ID: 27725263
[TBL] [Abstract][Full Text] [Related]
38. Palmitate induces interleukin-8 expression in human aortic vascular smooth muscle cells via Toll-like receptor 4/nuclear factor-κB pathway (TLR4/NF-κB-8).
Quan J; Liu J; Gao X; Liu J; Yang H; Chen W; Li W; Li Y; Yang W; Wang B
J Diabetes; 2014 Jan; 6(1):33-41. PubMed ID: 23826669
[TBL] [Abstract][Full Text] [Related]
39. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.
Yoon MJ; Lee GY; Chung JJ; Ahn YH; Hong SH; Kim JB
Diabetes; 2006 Sep; 55(9):2562-70. PubMed ID: 16936205
[TBL] [Abstract][Full Text] [Related]
40. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB.
Weigert C; Brodbeck K; Staiger H; Kausch C; Machicao F; Häring HU; Schleicher ED
J Biol Chem; 2004 Jun; 279(23):23942-52. PubMed ID: 15028733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
